Concepedia

Author

Β. Michael Ghadimi

University of Göttingen

Also Known As

B M Ghadimi, B M. Ghadimi, B Michael Ghadimi, B. Ghadimi, B. M. Ghadimi, B. Michael Ghadimi, B.  M.  Ghadimi, B.M Ghadimi, B.M. Ghadimi, B.Michael Ghadimi

167

Publications

6.2K

Citations

40

H-Index

87

Concepts

All Affiliations

University of GöttingenNational Cancer InstituteUniversitätsmedizin GöttingenNational Institutes of HealthCenter for Cancer Research
ΒM

About

Β. Michael Ghadimi is an author at University of Göttingen specializing in medicine, cancer research, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

22

1.5K

2

Health Sciences

5

5

254

3

Engineering

1

1

47

4

Natural Sciences

1

1

191

5

Social Sciences

1

1

35

Β. Michael Ghadimi

×

57

Publications

4.8K

Citations

34

H-Index

YearCitations

A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2

Shouhui Yang, Peijun He, Jian Wang,

Cancer Research

2016

406

Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer

Geng Zhang, Peijun He, Hanson Tan,

Clinical Cancer Research

2013

376

Effectiveness of Gene Expression Profiling for Response Prediction of Rectal Adenocarcinomas to Preoperative Chemoradiotherapy

Β. Michael Ghadimi, Marian Grade, Michael J. Difilippantonio,

Journal of Clinical Oncology

2005

343

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

Tanja Fehm, Arthur I. Sagalowsky, Edward Clifford,

PubMed

2002

311

DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma

Geng Zhang, Aaron J. Schetter, Peijun He,

PLoS ONE

2012

274

Specific Chromosomal Aberrations and Amplification of the AIB1 Nuclear Receptor Coactivator Gene in Pancreatic Carcinomas

Β. Michael Ghadimi, Evelin Schröck, Robert L. Walker,

American Journal Of Pathology

1999

197

Mutated <i>KRAS</i> results in overexpression of <i>DUSP4</i>, a MAP‐kinase phosphatase, and <i>SMYD3</i>, a histone methyltransferase, in rectal carcinomas

Jochen Gaedcke, Marian Grade, Klaus Jung,

Genes Chromosomes and Cancer

2010

191

The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa

Jochen Gaedcke, Marian Grade, Jordi Camps,

Clinical Cancer Research

2012

183

Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling

Georg Emons, Melanie Spitzner, Sebastian Reineke,

Molecular Cancer Research

2017

146

Phase II Trial of Carcinoembryonic Antigen Radioimmunotherapy With <sup>131</sup>I-Labetuzumab After Salvage Resection of Colorectal Metastases in the Liver: Five-Year Safety and Efficacy Results

Torsten Liersch, J. Meller, Bettina Kulle,

Journal of Clinical Oncology

2005

135

Page 1